SGAM
Smith Group Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,251
| Closed | -$207K | – | 161 |
|
|
2024
Q2 | $207K | Buy |
7,251
+42
| +0.6% | +$1.2K | 0.02% | 132 |
|
|
2024
Q1 | $211K | Buy |
+7,209
| New | +$211K | 0.01% | 176 |
|
|
2022
Q1 | $390K | Sell |
5,107
-3,767
| -42% | -$288K | 0.02% | 122 |
|
|
2021
Q4 | $534K | Sell |
8,874
-226
| -2% | -$13.6K | 0.02% | 144 |
|
|
2021
Q3 | $510K | Sell |
9,100
-135
| -1% | -$7.57K | 0.03% | 137 |
|
|
2021
Q2 | $560K | Sell |
9,235
-89
| -1% | -$5.4K | 0.03% | 126 |
|
|
2021
Q1 | $654K | Hold |
9,324
| – | – | 0.03% | 108 |
|
|
2020
Q4 | $558K | Sell |
9,324
-3,040
| -25% | -$182K | 0.03% | 125 |
|
|
2020
Q3 | $743K | Sell |
12,364
-1,958
| -14% | -$118K | 0.04% | 112 |
|
|
2020
Q2 | $751K | Sell |
14,322
-49
| -0.3% | -$2.57K | 0.04% | 112 |
|
|
2020
Q1 | $482K | Hold |
14,371
| – | – | 0.03% | 123 |
|
|
2019
Q4 | $651K | Sell |
14,371
-8,580
| -37% | -$389K | 0.03% | 127 |
|
|
2019
Q3 | $874K | Sell |
22,951
-4,180
| -15% | -$159K | 0.03% | 121 |
|
|
2019
Q2 | $1.18M | Buy |
27,131
+17,481
| +181% | +$760K | 0.04% | 115 |
|
|
2019
Q1 | $367K | Sell |
9,650
-31,240
| -76% | -$1.19M | 0.01% | 185 |
|
|
2018
Q4 | $1.76M | Buy |
+40,890
| New | +$1.76M | 0.06% | 142 |
|